Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Mixed-Effects Logistic Regression Model for Seasonal Improvement (Quartile Model). Variable | OR | 95% CI | p-Value: Vitamin D supplementation | 1.09 | 0.56 to 2.14 | 0.800

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Seasonal Variation of Plaque Psoriasis in Relation to Individualized MED-Adjusted Ultraviolet Exposure: A Cross-Sectional Study in Poland

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Seasonal Variation of Plaque Psoriasis in Relation to Individualized MED-Adjusted Ultraviolet Exposure: A Cross-Sectional Study in Poland

Cross-sectional study · Journal of Clinical Medicine · 2026

Original publication title

Seasonal Variation of Plaque Psoriasis in Relation to Individualized MED-Adjusted Ultraviolet Exposure: A Cross-Sectional Study in Poland

Michał Niedźwiedź; Agnieszka Czerwińska; Janusz Krzyścin; Joanna Narbutt; Aleksandra Lesiak

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Patient-perceived seasonality of psoriasis is frequently reported, yet the independent contribution of objectively quantified, individualized ultraviolet (UV) exposure remains insufficiently characterized. We evaluated seasonal variation in plaque psoriasis and its association with geocoded, phototype-adjusted ambient antipsoriatic radiant exposures (ARE) using mixed-effects modeling.

Methods:

This cross-sectional study included 119 adults with plaque psoriasis (476 seasonal observations). Participants rated seasonal disease courses using a 7-point scale. Ambient ARE was geocoded to residential postal codes and quantified as a behaviorally weighted dose normalized to individual minimal erythema dose (MED). Mixed-effects logistic regression models, adjusted for relevant confounders, estimated associations with seasonal improvement and worsening.

Results:

Seasonality was reported by 89.9% of participants (p < 0.001). Summer was the most favorable season, whereas winter was the most detrimental. The highest ARE quartile was independently associated with increased odds of improvement (OR 4.65, 95% CI 2.04 to 10.58, p < 0.001) and reduced odds of worsening (OR 0.16, 95% CI 0.08 to 0.33, p < 0.001). Crucially, continuous quadratic modeling revealed a significant inverted U-shaped relationship between UV exposure and improvement, with an estimated turning point of 3.85 (95% CI 1.88 to 5.82, p < 0.001) for the declared daily ARE (UVdecl) normalized by MED. Beyond this threshold, the probability of improvement attenuated. The protective effect against seasonal worsening remained linear.

Conclusions:

Psoriasis seasonality demonstrates a robust exposure: response association relationship with ambient UV. The estimated turning point (UVdecl/MED = 3.85) within our modeled exposure metric is exploratory and hypothesis-generating. It suggests an association where moderate UV exposure correlates with patient-perceived benefits, but these diminish at very high levels. This threshold requires external prospective validation before being considered a clinically actionable recommendation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Patient-perceived seasonality of psoriasis is frequently reported, yet the independent contribution of objectively quantified, individualized ultraviolet (UV) exposure remains insufficiently characterized. We evaluated seasonal variation in plaque psoriasis and its association with geocoded, phototype-adjusted ambient antipsoriatic radiant exposures (ARE) using mixed-effects modeling.

Source: Background:

Abstract: Results

Seasonality was reported by 89.9% of participants (p < 0.001). Summer was the most favorable season, whereas winter was the most detrimental. The highest ARE quartile was independently associated with increased odds of improvement (OR 4.65, 95% CI 2.04 to 10.58, p < 0.001) and reduced odds of worsening (OR 0.16, 95% CI 0.08 to 0.33, p < 0.001). Crucially, continuous quadratic modeling revealed a significant inverted U-shaped relationship between UV exposure and improvement, with an estimated turning point of 3.85 (95% CI 1.88 to 5.82, p < 0.001) for the declared daily ARE (UVdecl) normalized by MED. Beyond this threshold, the probability of improvement attenuated. The protective effect against seasonal worsening remained linear.

Source: Results:

Abstract: Conclusions

Psoriasis seasonality demonstrates a robust exposure: response association relationship with ambient UV. The estimated turning point (UVdecl/MED = 3.85) within our modeled exposure metric is exploratory and hypothesis-generating. It suggests an association where moderate UV exposure correlates with patient-perceived benefits, but these diminish at very high levels. This threshold requires external prospective validation before being considered a clinically actionable recommendation.

Source: Conclusions:
Authors’ abstract

Background:

Patient-perceived seasonality of psoriasis is frequently reported, yet the independent contribution of objectively quantified, individualized ultraviolet (UV) exposure remains insufficiently characterized. We evaluated seasonal variation in plaque psoriasis and its association with geocoded, phototype-adjusted ambient antipsoriatic radiant exposures (ARE) using mixed-effects modeling.

Methods:

This cross-sectional study included 119 adults with plaque psoriasis (476 seasonal observations). Participants rated seasonal disease courses using a 7-point scale. Ambient ARE was geocoded to residential postal codes and quantified as a behaviorally weighted dose normalized to individual minimal erythema dose (MED). Mixed-effects logistic regression models, adjusted for relevant confounders, estimated associations with seasonal improvement and worsening.

Results:

Seasonality was reported by 89.9% of participants (p < 0.001). Summer was the most favorable season, whereas winter was the most detrimental. The highest ARE quartile was independently associated with increased odds of improvement (OR 4.65, 95% CI 2.04 to 10.58, p < 0.001) and reduced odds of worsening (OR 0.16, 95% CI 0.08 to 0.33, p < 0.001). Crucially, continuous quadratic modeling revealed a significant inverted U-shaped relationship between UV exposure and improvement, with an estimated turning point of 3.85 (95% CI 1.88 to 5.82, p < 0.001) for the declared daily ARE (UVdecl) normalized by MED. Beyond this threshold, the probability of improvement attenuated. The protective effect against seasonal worsening remained linear.

Conclusions:

Psoriasis seasonality demonstrates a robust exposure: response association relationship with ambient UV. The estimated turning point (UVdecl/MED = 3.85) within our modeled exposure metric is exploratory and hypothesis-generating. It suggests an association where moderate UV exposure correlates with patient-perceived benefits, but these diminish at very high levels. This threshold requires external prospective validation before being considered a clinically actionable recommendation.

Publication and source details

Original title: Seasonal Variation of Plaque Psoriasis in Relation to Individualized MED-Adjusted Ultraviolet Exposure: A Cross-Sectional Study in Poland

Michał Niedźwiedź; Agnieszka Czerwińska; Janusz Krzyścin; Joanna Narbutt; Aleksandra Lesiak

Journal of Clinical Medicine · 2026

* Correspondence: michal.niedzwiedz@stud.umed.lodz.pl; Tel.: +48-42-201-5119© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Medical University of Lodzhttps://ror.org/02t4ekc95 500/1-064-01/503-11-001The APC was funded by the Medical University of Lodz (no. 500/1-064-01/503-11-001).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:30:40.826468+00:00

DOI: 10.3390/jcm15072708 · PMC13073465